|
|
Volumn 293, Issue 20, 2005, Pages 2458-
|
|
Longer-lasting osteoporosis drugs sought
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
ARZOXIFENE;
BAZEDOXIFENE;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM;
ESTROGEN;
IBANDRONIC ACID;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
LASOFOXIFENE;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY AMG 162;
PARATHYROID HORMONE;
PARATHYROID HORMONE[1-34];
RALOXIFENE;
RISEDRONIC ACID;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
UNCLASSIFIED DRUG;
VITAMIN D;
ZOLEDRONIC ACID;
DENOSUMAB;
IMIDAZOLE DERIVATIVE;
BREAST CANCER;
CANCER RISK;
CLINICAL TRIAL;
DIET;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG SAFETY;
EXERCISE;
FOOD AND DRUG ADMINISTRATION;
FRACTURE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
OSTEOPOROSIS;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
THROMBOEMBOLISM;
URINE INCONTINENCE;
UTERUS PROLAPSE;
ARTICLE;
ANTIBODIES, MONOCLONAL;
DIPHOSPHONATES;
HUMANS;
IMIDAZOLES;
OSTEOPOROSIS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TERIPARATIDE;
|
|
EID: 21044439346
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.293.20.2458 Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|